Oxford begins first human trial of Bundibugyo Ebola vaccine
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
🌍 Cross-language spread
This story first appeared in 🇧🇷 Portuguese coverage — 8.1 hours before PULSE detected it in English news.
Detected by matching proper nouns and figures that survive translation. Times reflect when each edition's coverage was first indexed.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Oxford begins first human trial of Bundibugyo Ebola vaccine" is generating significant coverage in the Health category, with 6 articles from 6 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The Telegraph, University of Oxford, Sky News and CEPI. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 2h ago.
Quick answers
Why is "Oxford begins first human trial of Bundibugyo Ebola vaccine" trending?
Because 6 independent news sources published 6 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- First Human Trial of Bundibugyo Ebola Vaccine Begins Bloomberg.com · 16h ago
- The Ugandan city where the race for a new Ebola vaccine will be won or lost The Telegraph · 16h ago
- Oxford's Bundibugyo ebolavirus response University of Oxford · 16h ago
- Human trials of new Ebola vaccine set to begin in UK Sky News · 16h ago
- CEPI-backed Bundibugyo ebolavirus vaccine trial launched by Oxford Vaccine Group CEPI · 16h ago
- UK starts first vaccine trial, eight weeks into Ebola emergency BBC · 16h ago
- Oxford begins first human trial of Bundibugyo Ebola vaccine Reuters · 16h ago
Topics
Related trends
Rebels in Congo see Ebola as chance to show governing credentials
Ebola has expanded its reach within Congo, affecting two additional provinces as health authorities monitor the situation.
The Ebola epidemic is getting out of control
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
First patients enrolled in record-breaking Ebola treatment trial in DRC
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
U.S. Citizen Tests Positive for Ebola in Democratic Republic of Congo
19 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Genomic epidemiology of the ongoing 2026 Bundibugyo Virus Disease outbreak in the Democratic Republic of the Congo
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
In Congo, health workers fighting Ebola go on strike after months without pay
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.